NRG Oncology   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Philadelphia PA United States (2014)

Organization Overview

First Clinical Trial
2014
NCT01134861
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NRG Oncology